Publications by authors named "Martin Pool"

Claim this Profile
N
No reinduction of clinically relevant radioiodine uptake after lenvatinib treatment in radioidine-refractory differentiated thyroid cancer.
Maaike Dotinga, Lioe-Fee de Geus-Oei, Floris H P van Velden, Mette K Stam, Jan W T Heemskerk, Martin Pool

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study).
Lianne Triemstra, Sarah W J M Spruijt, Dennis Vriens, Erik Vegt, Wilma E Mesker, Martin Pool

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity.
Oveena Fonseka, Rida Raja, Claire Ross, Sanskruti R Gare, Jiayan Zhang, Martin R Pool

Circulation· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac inotropy and cardiac calcium sensitization of PanLN800(-Forte), a cationic heptamethine indocyanine fluorescent contrast agent for intraoperative pan lymph node imaging.
Robin A Faber, Victor M Baart, Mark W Bordo, Taryn L March, Adrianus R P M Valentijn, Martin Pool

Toxicol Appl Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients.
Daan G J Linders, Okker D Bijlstra, Laura C Fallert, N Geeske Dekker-Ensink, Taryn L March, Martin Pool

Mol Imaging Biol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo fluorescence-guided resection margin assessment in breast cancer surgery using a topically applied, cathepsin-activatable imaging agent.
Daan G J Linders, Okker D Bijlstra, Ethan Walker, Taryn L March, Martin Pool

Pharmacol Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orchestrated centers for the production of proteins or "translation factories".
Robert A Crawford, Matthew Eastham, Martin R Pool, Mark P Ashe

Wiley Interdiscip Rev RNA· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.
Daan G J Linders, Okker D Bijlstra, Laura C Fallert, Denise E Hilling, Ethan Walker, Martin Pool

Mol Imaging Biol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial.
Maaike Dotinga, Dennis Vriens, Floris H P van Velden, Mette K Stam, Jan W T Heemskerk, Martin Pool

Diagnostics (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane protein biogenesis at the ER: the highways and byways.
Sarah O'Keefe, Martin R Pool, Stephen High

FEBS J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The current status and future prospects for molecular imaging-guided precision surgery.
Imke Boekestijn, Matthias N van Oosterom, Paolo Dell'Oglio, Floris H P van Velden, Martin Pool

Cancer Imaging· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zr-PET imaging to predict tumor uptake of Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma.
Danique Giesen, Marjolijn N Lub-de Hooge, Marcel Nijland, Helen Heyerdahl, Jostein Dahle, Martin Pool

Sci Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model.
Paolo Dell'Oglio, Danny M van Willigen, Matthias N van Oosterom, Kevin Bauwens, Fabian Hensbergen, Martin Pool

EJNMMI Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of Proteins for Translocation at the Endoplasmic Reticulum.
Martin R Pool

Int J Mol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probody Therapeutic Design of Zr-CX-072 Promotes Accumulation in PD-L1-Expressing Tumors Compared to Normal Murine Lymphoid Tissue.
Danique Giesen, Linda N Broer, Marjolijn N Lub-de Hooge, Irina Popova, Bruce Howng, Martin Pool

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition.
H Rudolf de Boer, Martin Pool, Esméé Joosten, Marieke Everts, Douwe F Samplonius

Oncogene· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The perplexing PEXEL protein secretory pathway.
Martin R Pool, Ilaria Russo

Nat Microbiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment.
Martin Pool, Arjan Kol, Steven de Jong, Elisabeth G E de Vries, Marjolijn N Lub-de Hooge

MAbs· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.
Martin Pool, H Rudolf de Boer, Marjolijn N Lub-de Hooge, Marcel A T M van Vugt, Elisabeth G E de Vries

Theranostics· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zr-Onartuzumab PET imaging of c-MET receptor dynamics.
Martin Pool, Anton G T Terwisscha van Scheltinga, Arjan Kol, Danique Giesen, Elisabeth G E de Vries

Eur J Nucl Med Mol Imaging· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells.
Arjan Kol, Anton Terwisscha van Scheltinga, Martin Pool, Christian Gerdes, Elisabeth de Vries

Oncotarget· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell biology: Sort of unexpected.
Martin R Pool

Nature· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab.
Martin Pool, Arjan Kol, Marjolijn N Lub-de Hooge, Christian A Gerdes, Steven de Jong

Oncotarget· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Opportunities for c-MET Visualization in the Clinic.
Martin Pool, Gooitzen M van Dam, Elisabeth G E de Vries

J Nucl Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAM.
Frank J Warnders, Stijn J H Waaijer, Martin Pool, Marjolijn N Lub-de Hooge, Matthias Friedrich

J Nucl Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis